Vesugen protocol · PepGuide

Standard

Course (10–20 days)

50–100u

1–2 mg SubQ · Daily

SubQ. (Oral bioregulator capsules dose higher.)

Between courses

1–3 courses per year.

Phase	How often	Dose	Units	Notes
Course (10–20 days)	Daily	1–2 mg SubQ	50–100u	SubQ. (Oral bioregulator capsules dose higher.)
Between courses	–	–	–	1–3 courses per year.

Units column is at 2 mg/mL. Note: vascular-targeted bioregulator; evidence is largely Russian research, limited Western RCTs.

Cycle & timing

Cycle: 10–20 day course, 1–3×/year.

Timing: Any time.

Where: SubQ, abdomen. Rotate.

What to expect

Proposed vascular support over a course; subtle, preliminary evidence.

How much to buy

For 20-day course @ 2 mg/day SubQ:

4

× 10mg vials

Men & women

Unisex peptide bioregulator, short courses, no sex-specific dosing; minimal human data. Avoid in pregnancy.

Dilution calculator

Set to the guide's typical mix for Vesugen. Change anything to see where to draw.

Vial size

BAC water added

Dose you want

Draw to

100u

Volume

1.00 mL

Strength

2 mg/mL

Doses per vial

5

Assumes a U-100 insulin syringe (100 units = 1 mL). Double-check against the compound's page before you draw.

Recommended mixes

Vial	Water	Strength
10 mg	5 mL	2 mg/mL

10 mg: 1 unit = 0.02 mg. A 1–2 mg SubQ dose = 50–100 units.

Storage

PowderFreeze-dried: -4°F.
MixedReconstituted: 36–46°F, up to the course length.

Don't use if: Active malignancy (theoretical, tissue gene-expression modulation) · Pregnancy and lactation · Hypersensitivity to the peptide

Stop if you notice

Persistent injection-site reaction
Any unexpected cardiovascular or systemic symptom
Pregnancy

Side effects

Generally well tolerated, mild injection-site reaction. Human safety data limited.

Drug interactions

No well-characterized interactions. Commonly stacked with other bioregulators in a course.

Labs

None compound-specific; vascular/blood-pressure tracking if that’s the goal.

What these labs mean →

Warnings

Limited Western clinical data, most evidence is Russian research. Quality varies, request a COA. Subtle, course-based effects.

Patient education

A short-course, vascular-targeted bioregulator; not continuous. Evidence is preliminary and largely Russian. Subtle effects; manage expectations. Request a COA; source quality matters.

These apply on top of the universal safety rules.

Pairs well with

Other Khavinson bioregulators

cellular/immune/vascular triad

Epithalon

Thymalin

Avoid with

Active malignancy

theoretical gene-expression effects

Pregnancy

Can Vesugen + Epithalon share a syringe?

Can share a syringe. Both are water-based. Combine them if you dose on the same schedule and site.

What it does

Evidence is largely from Russian bioregulator research; limited Western RCTs.

Vesugen is a Khavinson tripeptide (Lys-Glu-Asp, KED) targeting vascular tissue. It is proposed to support healthy endothelial/vascular gene expression and function. Evidence is largely from Russian bioregulator research; used as short pulsed courses.

References

researchdosing peptidedosages PubMed thepeptidereport

From the guide, page 104.